107 related articles for article (PubMed ID: 11324112)
1. Current concepts in HIV pathogenesis and treatment.
Gupta G
J Calif Dent Assoc; 2001 Feb; 29(2):129-35. PubMed ID: 11324112
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
6. Compliance with antiretroviral regimens.
Laurence J
AIDS Read; 2001 Apr; 11(4):177, 181. PubMed ID: 11392675
[No Abstract] [Full Text] [Related]
7. Patients who want to stop their medications: treatment interruptions in HIV infection.
Ball SC
AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449
[No Abstract] [Full Text] [Related]
8. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
9. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
Townsend ML; Jackson GL; Smith R; Wilson KH
Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and AIDS: new biology, therapeutic advances, and clinical implications. Introduction.
Miles SA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S1-2. PubMed ID: 9389309
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
12. [CBO guidelines 'Antiretroviral therapy in the Netherlands'].
Borleffs JC; Danner SA; Lange JM; van Everdingen JJ;
Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1585-9. PubMed ID: 11534375
[TBL] [Abstract][Full Text] [Related]
13. [Revised guideline "Antiretroviral Treatment"].
Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
[TBL] [Abstract][Full Text] [Related]
16. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
17. Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
Sufka SA; Ferrari G; Gryszowka VE; Wrin T; Fiscus SA; Tomaras GD; Staats HF; Patel DD; Sempowski GD; Hellmann NS; Weinhold KJ; Hicks CB
J Infect Dis; 2003 Apr; 187(7):1027-37. PubMed ID: 12660916
[TBL] [Abstract][Full Text] [Related]
18. Current status of HIV infection: a review for non-HIV-treating physicians.
Knoll B; Lassmann B; Temesgen Z
Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
[TBL] [Abstract][Full Text] [Related]
19. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Llibre JM; Domingo P; del Pozo MA; Miralles C; Galindo MJ; Viciana I; Moreno S; Schapiro JM; Clotet B
J Antimicrob Chemother; 2008 Jan; 61(1):206-9. PubMed ID: 17999972
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of HIV disease: opportunities for new prevention interventions.
Fauci AS
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S206-12. PubMed ID: 18190288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]